We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLDT
1851
Chatham Lodging
CLDT
$586M
| $2.29M | ﹤0.01% |
173,615
+1,759
| +1% | +$22.4K |
|
|
CSW
1852
CSW Industrials
CSW
$5.71B
| $2.28M | ﹤0.01% |
16,887
-1,314
| -7% | -$167K |
|
|
TWNK
1853
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $2.28M | ﹤0.01% |
158,960
-38,667
| -20% | -$568K |
|
1854
ICF International
ICFI
$1.72B
| $2.28M | ﹤0.01% |
26,067
-2,137
| -8% | -$179K |
|
1855
Maravai LifeSciences
MRVI
$919M
| $2.28M | ﹤0.01% |
+63,863
| New | +$2.12M |
|
|
SRG
1856
Seritage Growth Properties
SRG
$136M
| $2.26M | ﹤0.01% |
123,332
-1,535
| -1% | -$28.4K |
|
1857
First Busey Corp
BUSE
$2.56B
| $2.26M | ﹤0.01% |
88,071
-4,685
| -5% | -$111K |
|
|
CCF
1858
DELISTED
Chase Corporation
CCF
| $2.25M | ﹤0.01% |
19,343
-1,806
| -9% | -$202K |
|
1859
CarGurus
CARG
$3.47B
| $2.24M | ﹤0.01% |
93,848
-7,484
| -7% | -$217K |
|
1860
OceanFirst Financial
OCFC
$1.91B
| $2.23M | ﹤0.01% |
93,314
-5,739
| -6% | -$123K |
|
|
INFN
1861
DELISTED
Infinera Corporation Common Stock
INFN
| $2.23M | ﹤0.01% |
231,987
-16,725
| -7% | -$164K |
|
1862
Verra Mobility
VRRM
$744M
| $2.23M | ﹤0.01% |
164,813
-9,970
| -6% | -$138K |
|
1863
Comtech Telecommunications
CMTL
$51.8M
| $2.22M | ﹤0.01% |
89,312
+3,080
| +4% | +$78.3K |
|
|
MNR
1864
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $2.22M | ﹤0.01% |
125,270
-15,533
| -11% | -$274K |
|
|
KRTX
1865
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.21M | ﹤0.01% |
18,355
-1,633
| -8% | -$185K |
|
|
BRSP
1866
BrightSpire Capital
BRSP
$648M
| $2.2M | ﹤0.01% |
258,676
-28,180
| -10% | -$240K |
|
1867
Gray Television
GTN
$552M
| $2.19M | ﹤0.01% |
119,319
-12,157
| -9% | -$225K |
|
1868
TriMas Corp
TRS
$1.44B
| $2.19M | ﹤0.01% |
72,220
-5,477
| -7% | -$180K |
|
1869
Clearwater Paper
CLW
$376M
| $2.18M | ﹤0.01% |
57,876
+1,582
| +3% | +$63.1K |
|
1870
Allogene Therapeutics
ALLO
$694M
| $2.17M | ﹤0.01% |
61,362
-6,034
| -9% | -$204K |
|
1871
Goosehead Insurance
GSHD
$2.32B
| $2.17M | ﹤0.01% |
20,208
-1,132
| -5% | -$153K |
|
|
BLUE
1872
DELISTED
bluebird bio
BLUE
| $2.17M | ﹤0.01% |
5,544
-235
| -4% | -$116K |
|
1873
Virgin Galactic
SPCE
$398M
| $2.16M | ﹤0.01% |
3,523
-83
| -2% | -$62.5K |
|
1874
CryoPort
CYRX
$762M
| $2.16M | ﹤0.01% |
41,446
-510
| -1% | -$31K |
|
1875
Cooper-Standard Automotive
CPS
$558M
| $2.15M | ﹤0.01% |
59,273
+91
| +0.2% | +$3.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.